A Study Connecting Early Infant Stomach Tubes and Later Irritable Bowel Symptoms

Overview

About this study

The purpose of this study is to find out if having a stomach tube placed as a baby is connected to having greater chances of stomach or intestine problems later in life.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

  • ŸBorn July 1998-July 2002
  • Gestational age 34 0/7-36 6/7
  • ŸWell baby in Level 2 or 3 nursery
  • ŸFluency in English
  • ŸCases: Insertion of GT 0-6 weeksŸ
  • Controls: No GT 0-6 weeks

Exclusion CriteriaŸ

  • Documented or suspected genetic disorders
  • Complex congenital anomalies
  • Serious infection, received antibiotics >48 hours
  • Major medical comorbidities (e.g. intraventricular hemorrhage, stroke, patent ductus arteriosus, etc.)
  • ŸEndotracheal tube or nasal CPAP

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Yuri Saito Loftus, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions